Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Damage to the Lungs may take longer than was hoped to show the healing effects and be seen in a long term recovery.?. Expecting a strong patient uptrend at the 15 day Data point 'in humans' may have been too high an expectation.
Mortality? What can they say about that or most results except "positive trending"?

The 'positive trending' is certainly better than colonquin/others which were a negative.

The Secondary endpoints seem more realistic with effects of treatment time allowing it to fully work. Seems by this data that at the 15 day period it will just begin affecting recovery and 'I hope' to see Ifenprodil show stronger results given the extra time periods in the 28 day Secondary data.?.

Time to being on ventilation or coming off along with overall mortality and final time spent in a Hospital were all set for 28 day analysis.

I see medchem's reply to Top 3 question, thumbs up...

As stated in the PR, an EUA was granted for minor improvements from Rem. It was mentioned for a reason, I hope.?.

Ifenprodil doesn't seem to be the instant COVID-19 killer of our dreams but is showing some effectiveness and is safe with COVID patient's conditions. More time and that 28 day Data may still show Ifenprodil will be a stronger treatment than what is available now.?.
...GLTA...

science guys???